Genetron Holdings (Genetron Holdings) Change In Receivables : $0.00 Mil (TTM As of Jun. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Genetron Holdings Change In Receivables?

Genetron Holdings's change in receivables for the quarter that ended in Jun. 2022 was $0.00 Mil. It means Genetron Holdings's Accounts Receivable stayed the same from Mar. 2022 to Jun. 2022 .

Genetron Holdings's change in receivables for the fiscal year that ended in Dec. 2022 was $0.62 Mil. It means Genetron Holdings's Accounts Receivable declined by $0.62 Mil from Dec. 2021 to Dec. 2022 .

Genetron Holdings's Accounts Receivable for the quarter that ended in Jun. 2022 was $46.16 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Genetron Holdings's Days Sales Outstanding for the three months ended in Jun. 2022 was 204.73.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Genetron Holdings's liquidation value for the three months ended in Jun. 2022 was $48.32 Mil.

Genetron Holdings Change In Receivables Historical Data

The historical data trend for Genetron Holdings's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetron Holdings Change In Receivables Chart

Genetron Holdings Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Receivables

Get a 7-Day Free Trial

-5.10

-6.78

-18.02

-32.34

0.62

Genetron Holdings Quarterly Data
	Dec17	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22
Change In Receivables	Get a 7-Day Free Trial													-	-	-	-	-

Genetron Holdings Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Genetron Holdings (NAS:GTH) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Genetron Holdings's Days Sales Outstanding for the quarter that ended in Jun. 2022 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	46.161	/	20.574	*	91
=	204.73

2. In Ben Graham's calculation of liquidation value, Genetron Holdings's accounts receivable are only considered to be worth 75% of book value:

Genetron Holdings's liquidation value for the quarter that ended in Jun. 2022 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	70.6	-	61.005	+	0.75 * 46.161	+	0.5 * 8.218
=	48.32

Genetron Holdings Change In Receivables Related Terms

Thank you for viewing the detailed overview of Genetron Holdings's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetron Holdings (Genetron Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetron Holdings Ltd (NAS:GTH) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8 Life Science Parkway, 1-2nd Floor, Building 11, Zone 1, Changping District, Beijing, CHN, 102206

Website

https://www.genetronhealth.com

Genetron Holdings Ltd is an oncology company in China. It is specialized in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The company's operating segment includes Diagnosis and monitoring - provision for LDT services; Diagnosis and monitoring - sale of IVD products and Development services. It generates maximum revenue from the Diagnosis and monitoring - provision for LDT services segment.